Glaukos Announces First Quarter 2023 Financial Results : vim

Glaukos Corporation , an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, today announced... | May 3, 2023

Related Keywords

Thomas Burns , International Glaucoma , Ivantis Inc , Corneal Health , Glaukos Corporation , Avedro Inc , Exchange Commission , Investor Relations , Quarterly Summary , Micro Invasive Glaucoma Surgery , Annual Report , Quarterly Report , Investor Section , Regarding Use , Generally Accepted Accounting Principles , Glaukos Corporation Stock Exchange , News , Information , Press Release , Glaukos , Corporation , N , Ophthalmic , Medical , Technology , End , Harmaceutical , Company , Ocused , Novel , Therapies , Or , The , Treatment , F , Corneal , Disorders , Retinal , Oday Gkos Us3773221029 ,